Drug profile · INN
insulin lispro recombinant
HUMALOG KWIKPEN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
insulin lispro recombinant (HUMALOG KWIKPEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN insulin lispro recombinant
Brand HUMALOG KWIKPEN
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is insulin lispro recombinant?
insulin lispro recombinant (HUMALOG KWIKPEN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for insulin lispro recombinant?
HUMALOG KWIKPEN is a marketed brand name for insulin lispro recombinant. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin lispro recombinant?
insulin lispro recombinant has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.